1 Szyf, M, Pakneshan, P & Rabbani, SA (2004) DNA methylation and breast cancer. Biochem Pharmacol 68, 1187–1197.
2 Szyf, M (2005) DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc) 70, 533–549.
3 Jones, PA & Baylin, SB (2007) The epigenomics of cancer. Cell 128, 683–692.
4 Balch, C, Montgomery, JS, Paik, HI, et al. (2005) New anti-cancer strategies: epigenetic therapies and biomarkers. Front Biosci 10, 1897–1931.
5 Rice, JC, Ozcelik, H, Maxeiner, P, et al. (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761–1765.
6 Fujita, N, Jaye, DL, Kajita, M, et al. (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207–219.
7 Khan, S, Kumagai, T, Vora, J, et al. (2004) PTEN promoter is methylated in a proportion of invasive breast cancers. Int J Cancer 112, 407–410.
8 Garcia, JM, Silva, J, Pena, C, et al. (2004) Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer 41, 117–124.
9 Goel, A, Arnold, CN, Niedzwiecki, D, et al. (2004) Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 64, 3014–3021.
10 Montiel-Duarte, C, Cordeu, L, Agirre, X, et al. (2008) Resistance to Imatinib Mesylate-induced apoptosis in lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res 32, 709–716.
11 Besson, A, Robbins, SM & Yong, VW (1999) PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 263, 605–611.
12 Bigey, P, Ramchandani, S, Theberge, J, et al. (2000) Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene 242, 407–418.
13 Manna, SK, Mukhopadhyay, A & Aggarwal, BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509–6519.
14 Hisatake, J, O'Kelly, J, Uskokovic, MR, et al. (2001) Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 97, 2427–2433.
15 Wang, Q, Lee, D, Sysounthone, V, et al. (2001) 1,25-Dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67, 157–168.
16 Wu, Q, Chen, ZM & Su, WJ (2002) Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells. Int J Biochem Cell Biol 34, 1102–1114.
17 Arany, I, Whitehead, WE, Ember, IA, et al. (2003) Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells. Anticancer Res 23, 495–497.
18 Waite, KA, Sinden, MR & Eng, C (2005) Phytoestrogen exposure elevates PTEN levels. Hum Mol Genet 14, 1457–1463.
19 Campbell, PM & Szyf, M (2003) Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogenesis 24, 17–24.
20 McCabe, MT, Davis, JN & Day, ML (2005) Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 65, 3624–3632.
21 Niitsu, N, Hayashi, Y, Sugita, K, et al. (2001) Sensitization by 5-aza-2 ′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3. Br J Haematol 112, 315–326.
22 Mongan, NP & Gudas, LJ (2005) Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. Mol Cancer Ther 4, 477–486.
23 Pettitt, AR (2003) Mechanism of action of purine analogues in chronic lymphocytic leukaemia. Br J Haematol 121, 692–702.
24 Fabianowska-Majewska, K, Ruckemann, K, Duley, JA, et al. (1998) Effect of cladribine, fludarabine, and 5-aza-deoxycytidine on S-adenosylmethionine (SAM) and nucleotides pools in stimulated human lymphocytes. Adv Exp Med Biol 431, 531–535.
25 Wyczechowska, D & Fabianowska-Majewska, K (2003) The effects of cladribine and fludarabine on DNA methylation in K562 cells. Biochem Pharmacol 65, 219–225.
26 Stefanska, B, Rudnicka, K, Bednarek, A, et al. (2010) Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol 638, 47–53.
27 Christman, JK (2002) 5-Azacytidine and 5-aza-2 ′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483–5495.
28 Pfaffl, MW, Horgan, GW & Dempfle, L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36.
29 Iwase, H, Omoto, Y, Iwata, H, et al. (1999) DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br J Cancer 80, 1982–1986.
30 Saramaki, A, Diermeier, S, Kellner, R, et al. (2009) Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J Biol Chem 284, 8073–8082.
31 Milutinovic, S, Knox, JD & Szyf, M (2000) DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1). J Biol Chem 275, 6353–6359.
32 Iida, T, Suetake, I, Tajima, S, et al. (2002) PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells 7, 997–1007.
33 Tili, E, Michaille, JJ, Alder, H, et al. (2010) Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem Pharmacol 80, 2057–2065.
34 Chandra, J, Mansson, E, Gogvadze, V, et al. (2002) Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. Blood 99, 655–663.
35 Narvaez, CJ & Welsh, J (2001) Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 276, 9101–9107.
36 Chung, JH, Ostrowski, MC, Romigh, T, et al. (2006) The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet 15, 2553–2559.
37 Krawczyk, B, Rychlewski, P & Fabianowska-Majewska, K (2006) PTEN – tumour suppressor protein: regulation of protein activity and gene expression. Postepy Biologii Komorki 33, 365–380.
38 Pethe, V & Shekhar, PV (1999) Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J Biol Chem 274, 30969–30978.
39 Swami, S, Krishnan, AV & Feldman, D (2000) 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 6, 3371–3379.
40 Pratt, MA, Deonarine, D, Teixeira, C, et al. (1996) The AF-2 region of the RARa mediates retinoic acid inhibition of estrogen receptor function in human breast cancer cells. J Biol Chem 271, 20346–20353.
41 Bowers, JL, Tyulmenkov, VV, Jernigan, SC, et al. (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141, 3657–3667.
42 Vladusic, EA, Hornby, AE, Guerra-Vladusic, FK, et al. (2000) Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Rep 7, 157–167.
43 Warzocha, K, Fabianowska-Majewska, K, Blonski, J, et al. (1997) 2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia. Eur J Cancer 33, 170–173.
44 Pogribny, IP, Shpyleva, SI, Muskhelishvili, L, et al. (2009) Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutat Res 669, 56–62.
45 Widschwendter, M, Berger, J, Hermann, M, et al. (2000) Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 92, 826–832.
46 Niu, MY, Menard, M, Reed, JC, et al. (2001) Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells. Oncogene 20, 3506–3518.